MedTrace Logo

XIGDUO Extended Release (XR) Post Marketing Surveillance

NCT03038789 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 623

Last updated 2020-07-14

No results posted yet for this study

Summary

This is a local, prospective, non-interventional, regulatory postmarketing surveillance study. Adult patients with type 2 diabetes mellitus who are initiating Xigduo XR as indicated by the Ministry of Food and Drug Safety (MFDS) will be included.

Conditions

  • Adult Patients With Type 2 Diabetes Mellitus

Sponsors & Collaborators

Principal Investigators

  • JiSeong Yoon, PhD · YoungNam University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-20
Primary Completion
2019-08-30
Completion
2019-08-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03038789 on ClinicalTrials.gov